Save information for later
Sign Up

Learn About NUT Carcinoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top NUT Carcinoma Local Doctors?
Stephen E. Sallan
Elite in NUT Carcinoma
Elite in NUT Carcinoma
450 Brookline Avenue, Room 1642, 
Boston, MA 
Languages Spoken:
English

Stephen Sallan is a Pediatrics provider in Boston, Massachusetts. Dr. Sallan is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are NUT Carcinoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Adult T-Cell Leukemia.

Elite in NUT Carcinoma
Elite in NUT Carcinoma
Plantagenet, ON, CA 

Madeleine Lemieux practices in Plantagenet, Canada. Ms. Lemieux is rated as an Elite expert by MediFind in the treatment of NUT Carcinoma. Her top areas of expertise are NUT Carcinoma, Dilated Cardiomyopathy (DCM), Familial Dilated Cardiomyopathy, and Ewing Sarcoma.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in NUT Carcinoma
Hematology | Oncology
Elite in NUT Carcinoma
Hematology | Oncology

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
Languages Spoken:
English

Steven Dubois is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Dubois is rated as an Elite provider by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.

What are the latest NUT Carcinoma Clinical Trials?
A Phase 1 Study of the Bromodomain Inhibitor ZEN003694 in Combination With Platinum-based Chemotherapy in Patients With NUT Carcinoma

Summary: This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with cisplatin and etoposide or carboplatin and paclitaxel in treating patients with NUT carcinoma. Another purpose of this study is to see whether there are any changes in patient's tumor or blood characteristics (e.g. genes, molecules, etc.) due to combination therapy. ZEN003694 inhibits the production o...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1 Study of BET Bromodomain Inhibitor ZEN003694 in Combination With the CDK4/6 Inhibitor Abemaciclib in Patients With NUT Carcinoma, Breast Cancer and Other Solid Tumors

Summary: This phase I trial tests the safety, side effects, and best dose of a ZEN003694 when given together with abemaciclib in treating patients with NUT carcinoma, breast cancer or other solid tumors that have spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable). ZEN003694 is an inhibitor of a family of proteins called ...